EP3191120
NOTKUN IL-17 BLOKKA TIL AÐ HINDRA FRAMGANG VEFRÆNNA SKEMMDA HJÁ SJÚKLINGUM MEÐ SÓRALIÐAGIGT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.9.2015EP published:
10.4.2024EP application number:
15767597.6
EP translation filed:
16.7.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
7.9.2035Expiry date:
7.9.2026Next due date:
30.9.2026
Title in English:
USE OF IL-17 ANTAGONISTS TO INHIBIT THE PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PATIENTSLanguage of the patent:
English
Timeline
Today
8.9.2015EP application
10.4.2024EP Publication
16.7.2024Translation submitted
15.9.2024Registration published
7.9.2026Expires
Owner
Name:
NOVARTIS AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
MPOFU, ShephardAddress:
4002 Basel, CH
Name:
RICHARDS, HannoAddress:
4002 Basel, CH
Name:
LIGOZIO, GregoryAddress:
East Hanover, NJ 07936, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201462048512 PDate:
10.9.2014Country:
US
Classification
Categories:
A61K 39/00, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 26.8.2024
Expires: 7.9.2025
Payer: Zacco Denmark A/S
Number: 11
Paid: 9.9.2025
Expires: 7.9.2026
Payer: Árnason Faktor ehf.